About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Trp53tm1Ldo
targeted mutation 1, Lawrence A Donehower
MGI:2159430
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
Trp53tm1Ldo/Trp53+ B6.129S7-Trp53tm1Ldo MGI:3814544
ht2
Trp53tm1Ldo/Trp53+ involves: 129S7/SvEvBrd * C57BL/6 MGI:3814539
ht3
Trp53tm1Brd/Trp53tm1Ldo involves: 129S7/SvEvBrd * C57BL/6 MGI:3814538


Genotype
MGI:3814544
ht1
Allelic
Composition
Trp53tm1Ldo/Trp53+
Genetic
Background
B6.129S7-Trp53tm1Ldo
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53tm1Ldo mutation (1 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• serum IGF-1 levels are 34% of wild-type

endocrine/exocrine glands
• at 8, 12 and 24 weeks of age, mammary duct outgrowth is reduced compared to in wild-type mice
• however, proliferation and apoptosis are normal throughout development, pregnancy and involution and treatment with hormones or by cross mice to Tg(TTR-Igf1)1Jxu mice rescues outgrowth
• wild type mammary tissue transplanted into mice exhibits reduced outgrowth
• serial transplants of mammary epithelium exhibit decreased transplant capabilities compared to wild-type epithelium

integument
• at 8, 12 and 24 weeks of age, mammary duct outgrowth is reduced compared to in wild-type mice
• however, proliferation and apoptosis are normal throughout development, pregnancy and involution and treatment with hormones or by cross mice to Tg(TTR-Igf1)1Jxu mice rescues outgrowth
• wild type mammary tissue transplanted into mice exhibits reduced outgrowth
• serial transplants of mammary epithelium exhibit decreased transplant capabilities compared to wild-type epithelium




Genotype
MGI:3814539
ht2
Allelic
Composition
Trp53tm1Ldo/Trp53+
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53tm1Ldo mutation (1 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• old mice treated with Avertin or 5-fluorouracil exhibit increased mortality compared to similarly treated wild-type mice
• median lifespan is 96 weeks compared to 118 weeks for wild-type mice
• mice exhibit some phenotypes associated with premature ageing
• however, mice do not exhibit liver pathologies, hair graying, alopecia, atrophy of intestinal villi, skin ulcerations, amyloid depositions, brain atrophy, joint disease or cataracts

respiratory system
• one mouse develops a lung adenoma and another a well-differentiated bronchio-alveolar lung adenocarcinoma

homeostasis/metabolism
• following treatment with 5-fluorouracil, mice that survive fail to exhibit a robust recovery as do wild-type mice
• old mice treated with Avertin or 5-fluorouracil exhibit increased mortality compared to similarly treated wild-type mice
• in old mice

neoplasm
• one mouse develops a lung adenoma and another a well-differentiated bronchio-alveolar lung adenocarcinoma
• mice do not develop any life-threatening tumors over the course of their lifespan compared to 45% of wild-type mice

skeleton
• by 18 months of age, mice exhibit lordokyphosis
• at 24 months of age

muscle
• at 24 months of age, mean quadriceps mass is 2.5-fold lower than in wild-type mice
• in older mice

reproductive system
• at 24 months of age
• at 24 months of age

renal/urinary system
• at 24 months of age
• at 24 months of age

liver/biliary system
• at 24 months of age
• at 24 months of age

immune system
• at 24 months of age
• at 24 months of age

growth/size/body
• by 18 months of age

behavior/neurological
• at 24 months of age

cellular
• mouse embryonic fibroblasts are 2 to 4 fold more resistant to transformation than wild-type cells

endocrine/exocrine glands
• at 24 months of age
• at 24 months of age

hematopoietic system
• at 24 months of age
• at 24 months of age

adipose tissue
• at 24 months of age, mice display reduced adipose deposition compared to wild-type mice

integument
• at 24 months of age, mice display reduced adipose deposition compared to wild-type mice
• by 22 to 24 months of age, no hair growth is observed
• at 24 months of age




Genotype
MGI:3814538
ht3
Allelic
Composition
Trp53tm1Brd/Trp53tm1Ldo
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53tm1Brd mutation (5 available); any Trp53 mutation (232 available)
Trp53tm1Ldo mutation (1 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice survive 9 to 10 months

neoplasm
• tumorigenesis is slightly delayed compared to in Trp53tm1Brd homozygotes but mice still exhibit an increase in the numbers of T-cell lymphomas and soft tissue sarcomas compared to in wild-type mice

endocrine/exocrine glands





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory